Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Next-Gen Sequencing & Advances in qPCR

's Biography

, ,

Dr. Elde did his masters and Ph.D. at the University of Tromsø, Norway, which he completed in 1999. He then worked as a post-doc at the Biochemical Institute, University of Giessen, Germany, for almost two years. Since 2002 he has worked as a research manager at Biotec Pharmacon. In 2009 Biotec Pharmacon moved its enzyme business into a new subsidiary, called ArcticZymes, where Dr. Elde now work as the Head of Application Development. ArcticZymes develop, produces and sell unique, cold-adapted enzymes for use in research and diagnostics.


Removal of Contaminating DNA in Sensitive qPCR and RT-qPCR Applications

Wednesday, 14 November 2012 at 14:15

Add to Calendar ▼2012-11-14 14:15:002012-11-14 15:15:00Europe/LondonRemoval of Contaminating DNA in Sensitive qPCR and RT-qPCR

Contaminating DNA is a major problem in the sensitive PCR technology and we will in this presentation give an overview of the methods available to eliminate this problem.

Add to Calendar ▼2012-11-13 00:00:002012-11-14 00:00:00Europe/LondonNext-Gen Sequencing and Advances in